Endologix

Irvine, United States Founded: 1992 • Age: 34 yrs
Minimally invasive treatments for aortic disorders are developed and manufactured.
Request Access

About Endologix

Endologix is a company based in Irvine (United States) founded in 1992.. Endologix has completed 2 acquisitions, including Nellix and PQ Bypass. Endologix offers products and services including DETOUR System, EVAR Portfolio, ALTO, and AFX2. Endologix operates in a competitive market with competitors including Endoron Medical, Trivascular, Altura Medical, Aptus Endosystems and Remon Medical, among others.

  • Headquarter Irvine, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Endologix Llc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $52.2 M (USD), Debt – Conventional

    Apr 04, 2019

  • Investors
    Deerfield

    & 1 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Nellix

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Endologix

Endologix offers a comprehensive portfolio of products and services, including DETOUR System, EVAR Portfolio, ALTO, and AFX2. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Treats peripheral artery disease with minimally invasive interventions.

Provides treatments for aortic aneurysms and vascular conditions.

Offers advanced solutions for endovascular aneurysm repair.

Supports endovascular procedures for vascular health.

People of Endologix
Headcount 200-500
Employee Profiles 12
Board Members and Advisors 7
Employee Profiles
People
Chip Richter
VP, Health Economics & Reimbursement
People
Cindy Pinto
Chief Financial Officer
People
William Willis
VP, Quality
People
Matt Thompson
President & CEO

Unlock access to complete

Board Members and Advisors
people
Richard Mott
Executive Chairman

Unlock access to complete

Funding Insights of Endologix

  • Total Funding
  • Total Rounds 5
  • Last Round Debt – Conventional — $52.2M
  • First Round

    (27 Oct 2010)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2019 Amount Debt – Conventional - Endologix Valuation

investors

Aug, 2018 Amount Post-IPO - Endologix Valuation

investors

Apr, 2017 Amount Debt – Conventional - Endologix Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Endologix

Endologix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Deerfield and EW Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Healthcare ecosystem is supported through investment and innovation by Deerfield.
Founded Year Domain Location
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Endologix

Endologix has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Nellix and PQ Bypass. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Percutaneous approach for femoral artery bypass
2011
Medical device catering less invasive treatment of Abdominal Aortic Aneurysms
1994
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Endologix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Endologix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Endologix

Endologix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endoron Medical, Trivascular, Altura Medical, Aptus Endosystems and Remon Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
domain founded_year HQ Location
Designs and manufactures for endovascular aortic repair equipment
domain founded_year HQ Location
Endovascular devices for aortic aneurysms are developed.
domain founded_year HQ Location
Endograft anchoring systems for aortic aneurysms are developed.
domain founded_year HQ Location
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Endologix

Frequently Asked Questions about Endologix

When was Endologix founded?

Endologix was founded in 1992 and raised its 1st funding round 18 years after it was founded.

Where is Endologix located?

Endologix is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

What does Endologix do?

Endologix develops and manufactures minimally invasive treatments for aortic disorders. Endologixs flagship product is the Powerlink System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. It acquired Nellix, a developer of medical devices for the minimally invasive treatment of aortic aneurysms.

Who are the top competitors of Endologix?

Endologix's top competitors include Trivascular, Shanghai MicroPort Endovascular MedTech and Jotec.

What products or services does Endologix offer?

Endologix offers DETOUR System, EVAR Portfolio, ALTO, and AFX2.

How many acquisitions has Endologix made?

Endologix has made 2 acquisitions, including Nellix, and PQ Bypass.

Who are Endologix's investors?

Endologix has 2 investors. Key investors include Deerfield, and EW Healthcare Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available